Basic information Safety Supplier Related

bruceine A

Basic information Safety Supplier Related

bruceine A Basic information

Product Name:
bruceine A
Synonyms:
  • bruceine A
  • 13,20-Epoxy-3,11β,12α-trihydroxy-15β-(3-methyl-1-oxobutoxy)-2,16-dioxopicras-3-en-21-oic acid methyl ester
  • Dihydrobrusatol
  • NSC 310616
  • Bruceine A (Dihydrobrusatol
  • Bruceine A 25514-31-2
  • Brucea javanica A
  • NSC31616
CAS:
25514-31-2
MF:
C26H34O11
MW:
522.54
Mol File:
25514-31-2.mol
More
Less

bruceine A Chemical Properties

Boiling point:
712.6±60.0 °C(Predicted)
Density 
1.43±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
insoluble in EtOH; insoluble in H2O; ≥5.23 mg/mL in DMSO with gentle warming
form 
Powder
pka
8.81±0.70(Predicted)
color 
White to off-white
More
Less

bruceine A Usage And Synthesis

Chemical Properties

White crystalline powder, soluble in methanol, ethanol, DMSO and other organic solvents, derived from the fruit of bruce chinensis.

Uses

Bruceantin A acts as an anti-babesial quassinoid, extracted from the fruits of Brucea javanica, also an effective anti-trypanosomal agent in vitro. Cytotoxic agent.

Definition

ChEBI: Bruceine A is a quassinoid.

Biological Activity

ic50: 7.7 nm against the parasitescanine babesiosis is a tick-borne disease caused by the intraerythrocytic apicomplexan parasites, babesia gibsoni and b. canis. clinical signs of b. gibsoni infection are anemia, fever, thrombocytopenia, splenomegaly, lymphadenopathy, and lethargy. bruceine a, a natural quassinoid compound extracted from the brucea javanica (l.) merr. dried fruits, was reported to have antibabesial activity.

Physiological effects

Bruisein A has an effect of treating malignant tumor, antimalarial and anti-inflammatory.

in vitro

bruceine a inhibited the in-vitro babesia gibsoni growth in canine erythrocytes at lower concentration compared with the antibabesial drug diminazene aceturate and killed the parasites within 24 hr at a concentration of 25 nm [1].

in vivo

oral administration of bruceine a at a dosage of 6.4 mg/kg/day for 5 days resulted in no clinical findings in a dog. an untreated dog developed typical acute babesiosis symptoms including high fever, severe anemia, and complete loss of appetite and movement. however, the two bruceine a-treated dogs maintained their healthy conditions throughout the experimental period of 4 weeks [1].

target

Antifection | p65 | NF-kB | ROS

References

[1] nakao r, mizukami c, kawamura y, subeki, bawm s, yamasaki m, maede y, matsuura h, nabeta k, nonaka n, oku y, katakura k. evaluation of efficacy of bruceine a, a natural quassinoid compound extracted from a medicinal plant, brucea javanica, for canine babesiosis. j vet med sci. 2009 jan;71(1):33-41.

bruceine ASupplier

Chengdu PFID reference Technology Co., Ltd Gold
Tel
028-82610909 15882229804
Email
pufeide@foxmail.com
BioBioPha Co., Ltd.
Tel
0871-65217109 13211707573;
Email
y.liu@mail.biobiopha.com
Chengdu Biopurify Phytochemicals Ltd.
Tel
+86-028-82633397 18982077548
Email
cwb1@biopurify.cn
Nanjing Spring & Autumn Biological Engineering Co., Ltd.
Tel
025-84430028 13815430202
Email
sale02@cqherb.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com